Clinical Trials Directory

Trials / Unknown

UnknownNCT05592301

Patent Foramen Ovale (PFO) and Risk of Perioperative Stroke

Canadian Patent Foramen Ovale and Perioperative Stroke Evaluation Study (CAPPRES): A Feasibility Study

Status
Unknown
Phase
Study type
Observational
Enrollment
408 (estimated)
Sponsor
University Health Network, Toronto · Academic / Other
Sex
All
Age
18 Years – 110 Years
Healthy volunteers
Not accepted

Summary

This is a multi-centre, prospective cohort study to determine if asymptomatic PFO is a risk factor for developing perioperative overt and covert stroke in patients undergoing non-cardiac surgery.

Detailed description

There is emerging evidence regarding the increased risk of perioperative stroke in patients with PFO, leading to an important clinical practice question: whether PFO should be considered in the perioperative risk assessment in non-cardiac surgery patients. The evidence base, however, comes from retrospective studies with numerous limitations. Patients referred for general, orthopedic, urological, gynecologic, spinal, or thoracic surgery will be screened and consented during the surgery pre-admission clinic visit, and then undergo PFO screening using transcranial Doppler (TCD) and transthoracic echocardiography (TTE). Patients screened PFO+ (n=102) and matched PFO- controls (n=102) will have DW-MRI between postoperative days 2 and 7. Study personnel will conduct phone surveys at 30-day and 1-year post-surgery to collect data on other clinical outcomes. Patients will also be administered cognitive and patient-reported outcome measures assessments before enrollment, and 30-day and 1-year follow-up.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTDiffusion-weighted Magnetic Resonance Imaging (DW-MRI)The Diffusion-weighted Magnetic Resonance Imaging (DW-MRI) is used to diagnose perioperative stroke.
DIAGNOSTIC_TESTTranscranial Doppler (TCD)Used to diagnose PFO
DIAGNOSTIC_TESTTransthoracic Echocardiogram (TTE)Used to diagnose PFO.

Timeline

Start date
2023-07-07
Primary completion
2025-07-01
Completion
2025-07-01
First posted
2022-10-24
Last updated
2023-07-17

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT05592301. Inclusion in this directory is not an endorsement.